2023. According to a query on the official website of China Medical Network, the LEADPFA cardiac pulsed electric field ablation device and the PULSEDFA disposable cardiac pulsed electric field ablation catheter entered the special review procedure (green channel) for innovative medical devices of the China National Medical Products Administration (NMPA) in June 2022. The product registration application has been officially accepted by NMPA, and Jinjiang’s atrial fibrillation pulse ablation will be launched in China in the fourth quarter of 2023.